Reduction in use of Cyproterone/Ethinylestradiol (Diane‐35 and generics) after risk minimisation measures in the Netherlands, UK and Italy

Aug-19

Dermatology Endocrinology Gynecology and Obstetrics Pharmacoepidemiology Women's Health

AUTHORS : Fernie J.A. Penning-van Beest, PHARMO Institute for Drug Outcomes Research, Van Deventerlaan 30 /40, 3528 AE Utrecht, Netherlands – Email: pharmo@pharmo.nl

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 28(S2):529

DOI : 10.1002/pds.4864

Read more

More publications

Apr-25

Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study

Autoimmune Dermatology

Read more

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more